CareLit · DOI-Nachweis · Aktuelle Neurologie
Efficacy and safety of mitoxantrone in multiple sclerosis: a retrospective analysis of 105 patients
DOI 10.1055/s-2005-919397
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Spichtinger, H Koch, U Baumgart, I Kleiter, P Pöschl, E Rothenfußer-Korber, R Zellner, U Bogdahn, A Steinbrecher
ZeitschriftAktuelle Neurologie
Ausgabe10/2005
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Several controlled trials have shown mitoxantrone (MIX) to be effective in relapsing-remitting and secondary progressive multiple sclerosis (RRMS, SPMS). The MS therapy consensus group has recommended the use of MIX for treatment escalation in patients with progressive RRMS and SPMS refractory to immunomodulatory drugs. In clinical practice it is often difficult to decide which patients will be likely to…
Zitieren
Zitierempfehlung
A Spichtinger, H Koch, U Baumgart, I Kleiter, P Pöschl, E Rothenfußer-Korber, R Zellner, U Bogdahn, A Steinbrecher (2005) Efficacy and safety of mitoxantrone in multiple sclerosis: a retrospective analysis of 105 patients. Aktuelle Neurologie (10). https://doi.org/10.1055/s-2005-919397
Mit CareLit weiterarbeiten